A brief survey to characterize oxycodone abuse patterns in adolescents enrolled in two substance abuse recovery high schools

Am J Drug Alcohol Abuse. 2012 Mar;38(2):166-70. doi: 10.3109/00952990.2011.643994. Epub 2012 Jan 5.

Abstract

Background: Although oxycodone is one of the most widely available and abused opioids, little published information exists on the abuse of immediate-release oxycodone.

Objective: To obtain information on abuse of oxycodone and the effectiveness of abuse-deterrent strategies, especially for immediate-release oxycodone, we surveyed oxycodone abuse patterns in a population of experienced opioid abusers.

Methods: Students or recent graduates of two substance abuse recovery high schools in Massachusetts were surveyed on abuse behaviors with short-acting single-entity oxycodone (e.g., Roxicodone), short-acting combination oxycodone (e.g., Percocet), and extended-release oxycodone.

Results: Twenty-four students completed surveys. Mean age was 17.7 years (range 16-19), and mean age at first abuse of oxycodone was 15 (range 13-18). Overall, 56% of students reported oxycodone as their favorite prescription opioid to abuse. The primary preferred method of abuse of all oxycodone formulations was intranasal administration: 83% of single-entity oxycodone abusers preferred intranasal administration compared with 67% of combination oxycodone abusers and 69% of extended-release oxycodone abusers. Approximately half of our respondents preferred to ingest oxycodone orally, 25-38% of respondents swallowed the pill intact, and another 13-17% chewed the pill before swallowing. Maximum dose ever abused at one time ranged from 15 to 400 mg. Most respondents had abused ≥60 mg of oxycodone at a time.

Conclusions: In this small study, adolescent oxycodone abusers use high quantities of oxycodone at a time, alter routes of administration for not only extended-release but also immediate-release products, and commonly abuse single-entity oxycodone products. Abuse-deterrent formulations may be one strategy for addressing such behaviors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Intranasal
  • Adolescent
  • Age of Onset
  • Analgesics, Opioid / administration & dosage*
  • Female
  • Health Surveys
  • Humans
  • Male
  • Massachusetts
  • Opioid-Related Disorders / diagnosis*
  • Opioid-Related Disorders / therapy
  • Oxycodone / administration & dosage*
  • Young Adult

Substances

  • Analgesics, Opioid
  • Oxycodone